These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 19196659)
1. Antineoplastic activity of lentiviral vectors expressing interferon-alpha in a preclinical model of primary effusion lymphoma. Calabrò ML; Gasperini P; Di Gangi IM; Indraccolo S; Barbierato M; Amadori A; Chieco-Bianchi L Blood; 2009 May; 113(19):4525-33. PubMed ID: 19196659 [TBL] [Abstract][Full Text] [Related]
2. Crosstalk between the mesothelium and lymphomatous cells: insight into the mechanisms involved in the progression of body cavity lymphomas. Lignitto L; Mattiolo A; Negri E; Persano L; Gianesello L; Chieco-Bianchi L; Calabrò ML Cancer Med; 2014 Feb; 3(1):1-13. PubMed ID: 24402744 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha. Wu W; Rochford R; Toomey L; Harrington W; Feuer G Leuk Res; 2005 May; 29(5):545-55. PubMed ID: 15755507 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma. Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors. Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939 [TBL] [Abstract][Full Text] [Related]
6. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway. Takahashi-Makise N; Suzu S; Hiyoshi M; Ohsugi T; Katano H; Umezawa K; Okada S Int J Cancer; 2009 Sep; 125(6):1464-72. PubMed ID: 19521981 [TBL] [Abstract][Full Text] [Related]
8. YM155 induces apoptosis through proteasome-dependent degradation of MCL-1 in primary effusion lymphoma. Kojima Y; Hayakawa F; Morishita T; Sugimoto K; Minamikawa Y; Iwase M; Yamamoto H; Hirano D; Imoto N; Shimada K; Okada S; Kiyoi H Pharmacol Res; 2017 Jun; 120():242-251. PubMed ID: 28396094 [TBL] [Abstract][Full Text] [Related]
9. Diallyl trisulfide induces apoptosis by suppressing NF-κB signaling through destabilization of TRAF6 in primary effusion lymphoma. Shigemi Z; Furukawa Y; Hosokawa K; Minami S; Matsuhiro J; Nakata S; Watanabe T; Kagawa H; Nakagawa K; Takeda H; Fujimuro M Int J Oncol; 2016 Jan; 48(1):293-304. PubMed ID: 26647777 [TBL] [Abstract][Full Text] [Related]
10. Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma. Gasperini P; Tosato G Leukemia; 2009 Oct; 23(10):1867-74. PubMed ID: 19554030 [TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-κB pathway. Goto H; Kariya R; Shimamoto M; Kudo E; Taura M; Katano H; Okada S Cancer Sci; 2012 Apr; 103(4):775-81. PubMed ID: 22320346 [TBL] [Abstract][Full Text] [Related]
12. Combination of arsenic and interferon-α inhibits expression of KSHV latent transcripts and synergistically improves survival of mice with primary effusion lymphomas. El Hajj H; Ali J; Ghantous A; Hodroj D; Daher A; Zibara K; Journo C; Otrock Z; Zaatari G; Mahieux R; El Sabban M; Bazarbachi A; Abou Merhi R PLoS One; 2013; 8(11):e79474. PubMed ID: 24250827 [TBL] [Abstract][Full Text] [Related]
13. HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway. Kariya R; Taura M; Suzu S; Kai H; Katano H; Okada S Cancer Lett; 2014 Jan; 342(1):52-9. PubMed ID: 24012878 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models. Karam L; Houshaymi B; Abdel-Samad R; Jaafar M; Halloum I; Pisano C; Neipel F; Darwiche N; Abou Merhi R Oncol Rep; 2018 Feb; 39(2):721-730. PubMed ID: 29207182 [TBL] [Abstract][Full Text] [Related]